Ianalumab in Sjögren's syndrome: what can we learn from lupus trials? – Authors' reply
- Resource Type
- Correspondence
- Source
- In
The Lancet 10-16 September 2022 400(10355):808-809 - Subject
Analysis and Interpretation Correspondence - Language
- ISSN
- 0140-6736